164 related articles for article (PubMed ID: 37688628)
1. Androgen deprivation therapy caused a drastic proliferation of B-cell lymphoma with IgG4-related disease in patients with prostate cancer: a case report.
Sasagawa H; Numakura K; Mori M; Kobayashi M; Kashima S; Yamamoto R; Nara T; Saito M; Narita S; Nanjo H; Habuchi T
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15091-15094. PubMed ID: 37688628
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review.
Matsuo T; Tanaka T; Notohara K; Okada K
J Investig Med High Impact Case Rep; 2022; 10():23247096211067894. PubMed ID: 35038946
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
Wang H; Su T; Kang L; Yang L; Wang S
BMC Nephrol; 2020 Jul; 21(1):315. PubMed ID: 32727411
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Tamponade as an Initial Manifestation of Diffuse Large B-cell Lymphoma One Year after IgG4-related Disease in Remission.
Yamaji S; Kamezaki K; Shinchi M; Takizawa K; Abe C; Koike A; Kuroiwa M
Intern Med; 2024 Mar; 63(5):721-727. PubMed ID: 37438135
[TBL] [Abstract][Full Text] [Related]
5. Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer.
Uehara S; Yuasa T; Fujii Y; Yano A; Yamamoto S; Masuda H; Fukui I; Yonese J
BMC Res Notes; 2015 Aug; 8():335. PubMed ID: 26242866
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma.
Ishida M; Hodohara K; Yoshida K; Kagotani A; Iwai M; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(11):2560-8. PubMed ID: 24228121
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.
Ho RCW; Chan TSY; Au-Yeung R; Tang KHK; Hwang YY; Tse E; Kwong YL
Ann Hematol; 2022 Jan; 101(1):99-108. PubMed ID: 34767055
[TBL] [Abstract][Full Text] [Related]
9. Bilateral IgG4-related Ophthalmic Disease With Diffuse Large B-cell Lymphoma of the Right Eye: A Case Report.
Peng X; Jing H; He W
Ophthalmic Plast Reconstr Surg; 2020; 36(4):e84-e85. PubMed ID: 31923092
[TBL] [Abstract][Full Text] [Related]
10. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
Scherr DS; Pitts WR
J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
[TBL] [Abstract][Full Text] [Related]
11. Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy.
Tatenuma T; Miyamoto H
Drug Des Devel Ther; 2023; 17():2325-2333. PubMed ID: 37559910
[TBL] [Abstract][Full Text] [Related]
12. [Malignant lymphoma with IgG4-related disease arising in a very elderly man].
Nagae M; Onishi J; Umegaki H; Kuzuya M
Nihon Ronen Igakkai Zasshi; 2020; 57(3):321-326. PubMed ID: 32893215
[TBL] [Abstract][Full Text] [Related]
13. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
14. Intermittent complete androgen blockade in metastatic prostate cancer.
Rambeaud JJ
Eur Urol; 1999; 35 Suppl 1():32-6. PubMed ID: 10081701
[TBL] [Abstract][Full Text] [Related]
15. Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Pirozzi A; Cartenì G; Scagliarini S; Fusco M; Riccardi F
Medicine (Baltimore); 2019 Mar; 98(11):e14805. PubMed ID: 30882658
[TBL] [Abstract][Full Text] [Related]
16. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
Takuwa H; Tsuji W; Shintaku M; Yotsumoto F
BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860
[TBL] [Abstract][Full Text] [Related]
17. Preclinical characterization of a novel diphenyl benzamide selective ERα agonist for hormone therapy in prostate cancer.
Coss CC; Jones A; Parke DN; Narayanan R; Barrett CM; Kearbey JD; Veverka KA; Miller DD; Morton RA; Steiner MS; Dalton JT
Endocrinology; 2012 Mar; 153(3):1070-81. PubMed ID: 22294742
[TBL] [Abstract][Full Text] [Related]
18. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy.
Kruithof-Dekker IG; Têtu B; Janssen PJ; Van der Kwast TH
J Urol; 1996 Sep; 156(3):1194-7. PubMed ID: 8709345
[TBL] [Abstract][Full Text] [Related]
19. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
Scher HI; Liebertz C; Kelly WK; Mazumdar M; Brett C; Schwartz L; Kolvenbag G; Shapiro L; Schwartz M
J Clin Oncol; 1997 Aug; 15(8):2928-38. PubMed ID: 9256137
[TBL] [Abstract][Full Text] [Related]
20. Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with lower urinary tract symptoms (LUTS).
Nusrat A; Nazim SM
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
